Playback speed
10 seconds
Is Chemo the Key for EGFR Mutation-Positive NSCLC? The Data Too Good to Overlook
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
9,993 views
November 2, 2018
Dr. Jack West reviews the remarkable results of the NEJ009 trial that tested the combination ...
read more ↘ of carboplatin/pemetrexed with gefitinib as initial therapy compared to gefitinib followed by chemotherapy in patients with EGFR mutation-positive advanced NSCLC.
↖ read less
read more ↘ of carboplatin/pemetrexed with gefitinib as initial therapy compared to gefitinib followed by chemotherapy in patients with EGFR mutation-positive advanced NSCLC.
↖ read less
Comments 2
Login to view comments.
Click here to Login
Lung